Viewpoint News & Awards

Viewpoint Awarded $100,000 in IEDA Demo Funds

Des Moines, IA. Viewpoint is pleased to announce that the company has been awarded $100,000 by the Iowa Economic Development Authority following a final presentation of its business development plan to the IEDA Technology Commercialization Committee on Thursday, March 26th.  The final pitch to the IEDA TCC was presented by Co-Founders Frances Johnson MD (Chief Medical Officer) and Michael Schultz PhD (Chief Science Officer).  The company had been referred unanimously to present its commercialization plans to the TCC by the IEDA VentureNet review panel. “We could not be more pleased with this award.” says Dr Johnson. “Clearly, the committee felt that our technology and commercialization plans were well-thought out and that we are prepared to move forward.”

The award comes at a time when the company is experiencing considerable momentum toward early phase clinical trials of its new diagnostics and therapies for metastatic melanoma. “This is a big win for us in establishing the validity of our business model and value building activities.” says Dr Schultz. “The award allows us to focus on the achieving specific-technical risk-mitgating milestones in our business plan with great terms.  It’s a big win at this stage of company development.”

See more: